Facebook Linkedin RSS Twitter Youtube
Home 2024

Phase III clinical trials (Clinical trial)

StockWatch: Athira Pays Price as Alzheimer’s Candidate Fails Trial
Drug Discovery

StockWatch: Athira Pays Price as Alzheimer’s Candidate Fails Trial

Lecanemab Approval for Early Alzheimer’s Disease Hits Roadblock in Europe
Drug Discovery

Lecanemab Approval for Early Alzheimer’s Disease Hits Roadblock in Europe

Neoadjuvant Immunotherapy for Melanoma Shows Promise in Phase III Study
Cancer

Neoadjuvant Immunotherapy for Melanoma Shows Promise in Phase III Study

Antitumor Immunity Boosted by Chitin-Derived Vaccine Adjuvant
Cancer

Antitumor Immunity Boosted by Chitin-Derived Vaccine Adjuvant

Improving Cell Therapy Supply Chains
Bioprocessing

Improving Cell Therapy Supply Chains

Antimicrobial Resistance: Multiple Threats, Multiple Responses
Infectious Diseases

Antimicrobial Resistance: Multiple Threats, Multiple Responses

Pick Up the Pieces: Invivyd Engineers New COVID-19 Monoclonal Candidate
Coronavirus

Pick Up the Pieces: Invivyd Engineers New COVID-19 Monoclonal Candidate

Cancer Drug May Be Repurposed for Inflammatory Diseases
Cancer

Cancer Drug May Be Repurposed for Inflammatory Diseases

Emerging Infectious Diseases Prompt a Layered Response
Infectious Diseases

Emerging Infectious Diseases Prompt a Layered Response

Parkinson’s Disease Drug Slows ALS Progression in Clinical Trial
Drug Discovery

Parkinson’s Disease Drug Slows ALS Progression in Clinical Trial

123...10Page 1 of 10
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.